• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. NEXIVA MAXZERO; PERIPHERAL IV CATHETERS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. NEXIVA MAXZERO; PERIPHERAL IV CATHETERS Back to Search Results
Catalog Number 383557
Medical Device Problem Code Material Integrity Problem (2978)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/06/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
B3.The date received by manufacturer has been used for this field.H.3.A follow up mdr will be submitted if additional information, a device evaluation, or a device history review is completed.
 
Event or Problem Description
Problems with the non-return valve of peripheral venous catheters of the nexiva model.In concrete terms, it has been found that the non-return valves are not permeable.Response received on 1/7/2026: was the device being used in/on the patient when the problem occurred? yes, every time has the patient or user been harmed? if so, please explain.No.Were the nursing staff present when the problem occurred? yes, every time in case of leakage, please confirm the leaked liquid.No leaks.Was additional medical/drug intervention necessary? if so, please explain.No.
 
Additional Manufacturer Narrative
The complaint of problems with the maxzero connector could not be confirmed from the image and six representative 20g nexiva devices that were provided for investigation.A visual examination revealed no damage or defects on the image or returned samples.A functional test revealed no leaks or occlusions in the maxzero connector or iv catheter.There were no other similar complaints from the implicated lot.Although the representative samples, image, and manufacturing records do not support the complainant¿s description of the reported event, the complaint has been documented and will continue to be monitored as part of ongoing efforts to identify potential manufacturing related issues.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.Complaints received about this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the data collected for identification of emerging trends.
 
Event or Problem Description
No new information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEXIVA MAXZERO
Common Device Name
PERIPHERAL IV CATHETERS
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer (Section G)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key24131571
Report Number1710034-2026-00029
Device Sequence Number21432646
Product Code FOZ
UDI-Device Identifier00382903835577
UDI-Public(01)00382903835577(11)250425(17)280331(10)5115276
Combination Product (Y/N)N
Initial Reporter CountryBE
PMA/510(K) Number
K183399
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 02/18/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number383557
Device Lot Number5115276
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/06/2026
Supplement Date Received by Manufacturer02/18/2026
Initial Report FDA Received Date01/21/2026
Supplement Report FDA Received Date02/18/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/25/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-